Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.3 GBX
Market Cap: 252.6m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

EV/S
Enterprise Value to Sales

4.6
Current
2.2
Median
2.6
Industry
Higher than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
4.6
=
Enterprise Value
247.2m GBX
/
Revenue
53.3m GBP
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
4.3
2-Years Forward
EV/S
3.7
3-Years Forward
EV/S
3

See Also

Discover More